SANNA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.238
EU - Europa 1.478
AS - Asia 808
SA - Sud America 74
AF - Africa 22
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.210
PL - Polonia 498
RU - Federazione Russa 428
SG - Singapore 202
IT - Italia 187
CN - Cina 172
HK - Hong Kong 160
VN - Vietnam 109
IE - Irlanda 88
SE - Svezia 71
BR - Brasile 61
KR - Corea 53
FI - Finlandia 51
GB - Regno Unito 38
FR - Francia 32
DE - Germania 31
BD - Bangladesh 20
ID - Indonesia 20
IN - India 18
CA - Canada 15
JP - Giappone 15
AU - Australia 13
CH - Svizzera 13
NL - Olanda 13
TR - Turchia 9
ES - Italia 7
UA - Ucraina 7
IQ - Iraq 6
ZA - Sudafrica 6
CI - Costa d'Avorio 5
MX - Messico 5
AR - Argentina 4
JO - Giordania 4
AT - Austria 3
BE - Belgio 3
IL - Israele 3
NG - Nigeria 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NI - Nicaragua 2
PE - Perù 2
PK - Pakistan 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
BH - Bahrain 1
CG - Congo 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
Totale 4.634
Salva come PNG Salva come JPEG
Città #
Warsaw 497
Santa Clara 491
Ashburn 278
Fairfield 219
Singapore 142
Hong Kong 141
Woodbridge 111
Seattle 105
Cambridge 93
Dublin 88
Chandler 86
San Jose 74
Houston 73
Wilmington 67
Beijing 53
Seoul 49
Milan 41
Lawrence 35
Council Bluffs 33
Los Angeles 31
Altamura 30
Helsinki 30
Ann Arbor 28
Ho Chi Minh City 28
Dong Ket 26
Princeton 24
Buffalo 23
Rome 23
Lauterbourg 18
New York 18
Florence 17
Jakarta 17
Clifton 15
Munich 14
Shanghai 14
Boston 13
Hanoi 13
Medford 13
The Dalles 13
Tokyo 13
Bern 12
Melbourne 12
Mumbai 12
Dallas 11
Jacksonville 11
Kent 11
Manchester 10
Paris 10
Figino 8
Hefei 8
Moscow 8
San Diego 8
Toronto 8
Boardman 7
Izmir 7
Atlanta 6
Barnet 6
Da Nang 6
Guangzhou 6
Redondo Beach 6
Utrecht 6
Yubileyny 6
Abidjan 5
Barcelona 5
Frankfurt am Main 5
London 5
San Francisco 5
São Paulo 5
Altrincham 4
Heemstede 4
Johannesburg 4
Lappeenranta 4
Naples 4
Phoenix 4
Turku 4
Abuja 3
Acton 3
Baghdad 3
Bologna 3
Brooklyn 3
Brussels 3
Catania 3
Chicago 3
Dalseong-gun 3
Denver 3
Haiphong 3
Milwaukee 3
Norwalk 3
Nuremberg 3
Tel Aviv 3
Turin 3
Vienna 3
Bauru 2
Berlin 2
Bishkek 2
Biên Hòa 2
Brasília 2
Bucharest 2
Cape Town 2
Charlotte 2
Totale 3.407
Salva come PNG Salva come JPEG
Nome #
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis 324
Hepcidin levels and their determinants in different types of myelodysplastic syndromes 311
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. 260
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine. 243
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine. 230
Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients. 229
Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. 222
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia 216
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents 205
Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients. 202
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine 199
Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells. 193
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis 188
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study 187
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. 186
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. 181
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents 178
Effects of erythropoiesis-stimulating agents on overall survival of international prognostic scoring system low/intermediate-1 risk, transfusion-inde-pendent myelodysplastic syndrome patients: A cohort study 175
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems 168
Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience 156
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS? 148
Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine 148
Response to luspatercept can be predicted and improves overall survival in the real‐life treatment of LR‐MDS 68
Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents 36
Leukemia cutis as a transient alarm bell of disease progression in a patient with chronic lymphocytic leukemia under watchful waiting 25
Totale 4.678
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022154 4 18 5 1 6 15 5 5 6 19 21 49
2022/2023409 30 75 26 13 37 76 55 24 47 2 8 16
2023/2024137 5 21 21 6 5 21 10 25 3 4 12 4
2024/20251.246 42 126 68 179 334 250 6 94 29 48 40 30
2025/20261.331 116 152 76 49 210 59 184 54 78 127 51 175
2026/20274 4 0 0 0 0 0 0 0 0 0 0 0
Totale 4.678